Illustration of a brain lesion transforming into healthy neurons, symbolizing MS diagnosis.

Unlocking the Mystery: How a Unique Brain Lesion Led to a Rare MS Diagnosis in a Child

Theo Raines in Health & Wellness November 2025 • 4 min read.

"Exploring Tumefactive Demyelinating Lesions and the Role of Advanced Imaging in Diagnosing Pediatric Multiple Sclerosis"

Multiple sclerosis (MS) in children is rare, affecting approximately 1 in 100,000 individuals. Within this already small group, the occurrence of tumefactive demyelinating lesions (TDLs)—large, tumor-like lesions in the brain—is even more exceptional. TDLs present a significant diagnostic challenge because their appearance can mimic brain tumors, leading to invasive procedures like brain biopsies.

A recent case highlights the complexities of diagnosing MS in children. The presence of a TDL in a 9-year-old girl initially raised concerns about a possible brain tumor. However, advanced imaging techniques, specifically MR spectroscopy (MRS), played a crucial role in differentiating the lesion and ultimately led to the correct diagnosis of MS.

This article delves into the specifics of this case, exploring the characteristics of TDLs, the utility of MRS in diagnosis, and the broader implications for understanding and managing pediatric MS.

What are Tumefactive Demyelinating Lesions (TDLs)?

Illustration of a brain lesion transforming into healthy neurons, symbolizing MS diagnosis.

Tumefactive demyelinating lesions are defined as large demyelinating lesions, typically exceeding 2 cm in diameter, that occur in the brain or spinal cord. Demyelination is the process where the myelin sheath, the protective covering of nerve fibers, is damaged. This damage disrupts the transmission of nerve signals, leading to various neurological symptoms.

TDLs are relatively rare, accounting for only 1-2 out of every 1,000 MS cases. What makes them particularly challenging is their appearance on imaging scans. TDLs often present with significant swelling (edema) and enhancement after contrast administration, features that are commonly associated with brain tumors. This overlap in imaging characteristics makes it difficult to distinguish between TDLs and tumors based on conventional MRI alone.

Size Matters: TDLs are larger than typical MS lesions, often exceeding 2 cm.
Swelling and Enhancement: The presence of edema and contrast enhancement mimics tumor appearance.
Rarity: TDLs are uncommon, even within the MS population.

In the case of the 9-year-old girl, the initial MRI revealed a 5 cm lesion in the right basal ganglia, an area deep within the brain. The lesion exhibited open ring enhancement, a pattern where the enhancing portion of the lesion forms an incomplete ring, with the open part facing the brain's outer layer (cortex). While suggestive of demyelination, this pattern alone wasn't enough to rule out a tumor.

The Critical Role of Accurate Diagnosis

This case underscores the importance of vigilance and advanced diagnostic techniques in evaluating neurological symptoms in children. While tumefactive demyelinating lesions are rare, they must be considered in the differential diagnosis of brain lesions, especially when MS is a possibility. The integration of MRS into the diagnostic workup can provide valuable insights, potentially avoiding unnecessary invasive procedures and ensuring timely initiation of appropriate treatment.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What exactly are tumefactive demyelinating lesions (TDLs), and why are they so difficult to diagnose?

Tumefactive demyelinating lesions (TDLs) are large demyelinating lesions in the brain or spinal cord, typically larger than 2 cm in diameter. Demyelination refers to the damage of the myelin sheath, which is the protective covering of nerve fibers. This damage disrupts nerve signal transmission, leading to various neurological symptoms. TDLs are rare and can be mistaken for brain tumors due to swelling (edema) and contrast enhancement on imaging scans. These characteristics make diagnosis challenging and emphasize the need for advanced imaging techniques.

How does MR spectroscopy (MRS) help in differentiating between tumefactive demyelinating lesions (TDLs) and brain tumors?

MR spectroscopy (MRS) is an advanced imaging technique that analyzes the biochemical composition of brain tissue. In the context of tumefactive demyelinating lesions (TDLs), MRS helps differentiate between TDLs and brain tumors by assessing the metabolic profile of the lesion. For example, MRS can detect specific metabolites, such as elevated levels of choline in tumors, which are not typically found in TDLs. By providing insights into the chemical makeup of the lesion, MRS aids in accurate diagnosis and can prevent unnecessary invasive procedures like brain biopsies.

How rare are tumefactive demyelinating lesions (TDLs) in children with multiple sclerosis (MS), and what implications does this rarity have for diagnosis?

While tumefactive demyelinating lesions (TDLs) are relatively rare in the general multiple sclerosis (MS) population, pediatric MS patients are even less likely to present with TDLs. Specifically, TDLs are found in only 1-2 out of every 1,000 MS cases. This rarity means that when a child presents with a large brain lesion, TDLs may not be the first consideration. Therefore, clinicians need to be vigilant and consider TDLs in the differential diagnosis, especially when MS is suspected. The case highlights the need for advanced imaging techniques like MR spectroscopy (MRS) to ensure accurate and timely diagnosis.

What does "open ring enhancement" mean in the context of brain lesions, and how does it relate to tumefactive demyelinating lesions (TDLs)?

An open ring enhancement refers to a specific pattern observed on MRI scans of brain lesions, where the enhancing portion of the lesion forms an incomplete ring. In the case of tumefactive demyelinating lesions (TDLs), the open part of the ring typically faces the brain's outer layer, the cortex. While this pattern is suggestive of demyelination, it is not definitive for distinguishing TDLs from other conditions like brain tumors. The presence of open ring enhancement, along with other clinical and imaging findings, contributes to the diagnostic process, particularly when combined with advanced techniques such as MR spectroscopy (MRS).

Why is early and accurate diagnosis so important in cases of multiple sclerosis (MS) presenting with tumefactive demyelinating lesions (TDLs)?

Early and accurate diagnosis of multiple sclerosis (MS), particularly when it presents atypically with tumefactive demyelinating lesions (TDLs), is crucial for several reasons. Firstly, it helps to avoid unnecessary invasive procedures, such as brain biopsies, which carry risks and can delay appropriate treatment. Secondly, timely diagnosis allows for the prompt initiation of disease-modifying therapies, which can help to slow the progression of MS and reduce the accumulation of neurological damage. Finally, it enables clinicians to provide appropriate supportive care and counseling to patients and their families, improving their overall quality of life. The case emphasizes the value of using advanced imaging techniques like MR spectroscopy (MRS) to facilitate early and accurate diagnosis, ultimately leading to better outcomes for children with MS.